This biotech stock still Wolfe's top pick as multiple catalysts loomh
Wolfe Research raised its price target on a biotechnology company for the second time this year, calling it a top ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
